IL10 and autoimmune disease: Future investigation will analyze a possible impact of increased IL-10 production by CD83Tg B cells in vivo, especially if CD83Tg B cells share features with IL-10 producing regulatory B cells [33]–[35] that have been described to be beneficial in various autoimmune disease models such as the recovery from EAE in resistant B6 mice [36].